pd 98059 has been researched along with glyceryl 2-arachidonate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delwel, R; Jordà , MA; Lowenberg, B | 1 |
| Clemente, D; Correa, F; Docagne, F; Guaza, C; Mestre, L | 1 |
| He, F; Njie, YF; Qiao, Z; Song, ZH | 1 |
3 other study(ies) available for pd 98059 and glyceryl 2-arachidonate
| Article | Year |
|---|---|
The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation.
Topics: Arachidonic Acids; Butadienes; Cell Differentiation; Cell Division; Cell Line; Chemotaxis, Leukocyte; Chromones; Endocannabinoids; Enzyme Inhibitors; Flavonoids; Glycerides; Granulocyte Colony-Stimulating Factor; Humans; Interleukin-3; Mitogen-Activated Protein Kinases; Morpholines; Neutrophils; Nitriles; Oncogene Proteins; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Mas; Receptors, Cannabinoid; Receptors, Drug; Recombinant Fusion Proteins; Signal Transduction | 2003 |
The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection.
Topics: Animals; Arachidonic Acids; Benzoxazines; Brain; Cell Nucleus; Cell Survival; Chromones; Cyclooxygenase 2; Dinoprostone; Endocannabinoids; Endothelial Cells; Enzyme Activation; Flavonoids; Fluorescent Antibody Technique; Glycerides; Imidazoles; Mice; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Morpholines; Naphthalenes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Pyridines; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Theilovirus | 2006 |
Aqueous humor outflow effects of 2-arachidonylglycerol.
Topics: Animals; Aqueous Humor; Arachidonic Acids; Calcium-Calmodulin-Dependent Protein Kinases; Camphanes; Cannabinoid Receptor Modulators; Cytoskeleton; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Flavonoids; Glycerides; Monoacylglycerol Lipases; Organ Culture Techniques; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Signal Transduction; Sus scrofa; Trabecular Meshwork | 2008 |